Oncaspar and platelet count decreased Patient Reports February 11, 2012

Oncaspar Side Effects Report #5231487-2
Oncaspar side effect was reported by a Physician from UNITED STATES on Jan 23, 2007. Female patient, 75 years of age, was diagnosed with peritoneal carcinoma and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: abasia, asthenia, balance disorder, feeding disorder, neuropathy peripheral, neutropenia, platelet count decreased. Oncaspar dosage: unknown. During the same period patient was treated with GEMCITABINE, PROPAFENONE, COZAAR, SYNTHROID, ESTERASE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Oncaspar Side Effects Report #5084454-6
Oncaspar side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Female patient, 18 years of age, weighting 124.1 lb, was diagnosed with b precursor type acute leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, hypotension, paraesthesia oral, platelet count decreased, pruritus, pulmonary haemorrhage, pulmonary oedema, rash , throat tightness. Oncaspar dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Oncaspar Side Effects Report #5853241-0
Oncaspar side effect was reported by a Physician from UNITED STATES on Aug 06, 2008. Male patient, 45 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, brain injury, cerebral haemorrhage, convulsion, deep vein thrombosis , platelet count decreased, prothrombin time prolonged, superior sagittal sinus thrombosis. Oncaspar dosage: unknown. During the same period patient was treated with GLEEVEC. Patient died.

Oncaspar Side Effects Report #5853241-0
Oncaspar side effect was reported by a Physician from UNITED STATES on Aug 06, 2008. Male patient, 45 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen decreased, brain injury, cerebral haemorrhage, convulsion, deep vein thrombosis , platelet count decreased, prothrombin time prolonged, superior sagittal sinus thrombosis. Oncaspar dosage: unknown. During the same period patient was treated with GLEEVEC. Patient died.


Oncaspar Side Effects Report #5732647-4
Oncaspar side effect was reported by a Pharmacist from UNITED STATES on Apr 24, 2008. Female patient, child 3 years of age, weighting 37.04 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypersensitivity, platelet count decreased, white blood cell count decreased. Oncaspar dosage: unknown. During the same period patient was treated with VINCRISTINE, METHOTREXATE, TYLENOL, BENADRYL. Patient was hospitalized. Patient recovered.

Oncaspar Side Effects Report #5156531-2
Oncaspar side effect was reported by a Physician from UNITED STATES on Nov 01, 2006. Female patient, 75 years of age, was treated with Oncaspar. After drug was administered, patient experienced the following side effects: abasia, activities of daily living impaired, balance disorder, neutropenia, peripheral sensorimotor neuropathy, platelet count decreased. Oncaspar dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.